Ym. Lee et al., Lymphoedema care of breast cancer patients in a breast care clinic: a survey of knowledge and health practice, SUPP CARE C, 9(8), 2001, pp. 634-641
Lymphoedema, an accumulation of protein-rich fluid in interstitial tissue,
is a well-recognised life-altering result of breast cancer treatment. With
the goal of studying the prevalence and management of lymphoedema after bre
ast cancer therapy, 171 patients were invited to complete a self-administer
ed questionnaire following completion of treatment for breast cancer. The s
urvey revealed that 82.5% of patients knew they were at risk of developing
lymphoedema. However, the level of knowledge about preventive care in lymph
oedema was inadequate, with a mean score of 4.07 out of a full mark of 10 (
SD=2.35, mode=2). A substantial proportion (45.6%; n=78) of respondents rep
orted that they had experienced lymphoedema and subsequently developed mult
iple sites of lymphoedema, but only 34.7% (n=26) had been referred for phys
iotherapy. The study also revealed that patients who had received the combi
ned regimen of mastectomy, lymph node dissection, radiotherapy and chemothe
rapy were at a higher risk of developing lymphoedema (X-2=6.305, P=0.043).
Interestingly, it was found that nurses were the most frequently cited reso
urce for information, but the least consulted professionals for discussion
on treatment. It is apparent from our patient survey that there is a lack o
f knowledge on lymphoedema care amongst breast cancer patients. In order to
improve patients' level of knowledge and their awareness of lymphoedema ca
re, the provision for systematic and comprehensive patient education, inclu
ding management protocols for lymphoedema, needs to be addressed. Education
and training, will be essential components of efforts to ensure appropriat
e care for lymphoedema patients.